Correlation Between Champions Oncology and Evogene
Can any of the company-specific risk be diversified away by investing in both Champions Oncology and Evogene at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Champions Oncology and Evogene into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Champions Oncology and Evogene, you can compare the effects of market volatilities on Champions Oncology and Evogene and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Champions Oncology with a short position of Evogene. Check out your portfolio center. Please also check ongoing floating volatility patterns of Champions Oncology and Evogene.
Diversification Opportunities for Champions Oncology and Evogene
0.14 | Correlation Coefficient |
Average diversification
The 3 months correlation between Champions and Evogene is 0.14. Overlapping area represents the amount of risk that can be diversified away by holding Champions Oncology and Evogene in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Evogene and Champions Oncology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Champions Oncology are associated (or correlated) with Evogene. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Evogene has no effect on the direction of Champions Oncology i.e., Champions Oncology and Evogene go up and down completely randomly.
Pair Corralation between Champions Oncology and Evogene
Given the investment horizon of 90 days Champions Oncology is expected to generate 0.88 times more return on investment than Evogene. However, Champions Oncology is 1.14 times less risky than Evogene. It trades about 0.08 of its potential returns per unit of risk. Evogene is currently generating about -0.38 per unit of risk. If you would invest 398.00 in Champions Oncology on August 28, 2024 and sell it today you would earn a total of 20.00 from holding Champions Oncology or generate 5.03% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Champions Oncology vs. Evogene
Performance |
| Timeline |
| Champions Oncology |
| Evogene |
Champions Oncology and Evogene Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Champions Oncology and Evogene
The main advantage of trading using opposite Champions Oncology and Evogene positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Champions Oncology position performs unexpectedly, Evogene can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Evogene will offset losses from the drop in Evogene's long position.| Champions Oncology vs. Molecular Partners AG | Champions Oncology vs. MediciNova | Champions Oncology vs. Anebulo Pharmaceuticals | Champions Oncology vs. Shattuck Labs |
| Evogene vs. Arcus Biosciences | Evogene vs. Fate Therapeutics | Evogene vs. Pluri Inc | Evogene vs. Lexaria Bioscience Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Other Complementary Tools
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |